Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT05245513

Enhancing Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial

The aims of the current study are to: Aim 1. Develop and refine a novel intervention protocol for individuals receiving medication treatment for opioid use disorder that assertively links them to recovery community centers; Aim 2. Determine the feasibility, acceptability, and preliminary efficacy of assertive linkage to recovery community centers relative to a matched control condition, via a pilot randomized controlled trial; Aim 3. Explain quantitative findings by gaining an in-depth understanding of the intervention's feasibility, acceptability, and preliminary efficacy via qualitative interviews.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location contact

Lauren A Hoffman, PhD

CONTACT

[email protected]

617-643-4690

About this study

This 5-year project seek to advance our understanding of the clinical and public health utility of recovery community centers and help bridge the gap between clinical treatment and community-based recovery support services. As a first step in this work, the investigators will develop and test a new intervention for peer-facilitated assertive linkage of patients receiving opioid use disorder pharmacotherapy to recovery community centers (RCCL), relative to a matched control condition (CC). This study aims to: Aim 1. Develop, manualize, and refine RCCL and CC protocols via stakeholder feedback. RCCL and CC protocols will be developed and manualized by adapting published community-based mutual-help linkage protocols. Upon preliminary manual development, feedback cycles will be conducted with relevant stakeholders (recovery coaches, recovery community center members, pharmacotherapy prescribers) to inform protocol revision, and promote its feasibility, acceptability, and adoptability. Aim 2. Determine the feasibility, acceptability, and preliminary efficacy of RCCL versus CC, via a pilot randomized controlled trial. More specifically, the feasibility of study procedures and RCCL/CC interventions, acceptability of interventions, and preliminary efficacy of RCCL relative to CC will be assessed. Aim 3. Explain quantitative findings by gaining an in-depth understanding of RCCL feasibility, acceptability, and efficacy via qualitative interviews in a subset of RCCL participants, peer facilitators, and linkage managers.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age ≥ 18 years
  • past-year opioid use disorder diagnosis per the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition
  • currently undergoing outpatient buprenorphine treatment through a provider or program at Massachusetts General Hospital
  • current residence in Massachusetts

Exclusion criteria

  • non-English fluency
  • active suicidality
  • neurodevelopmental disorders or neural trauma preventing informed consent
  • active psychosis
  • past-year attendance at a recovery community center or recovery support center

Treatment and study plan

Recovery Community Center Linkage (RCCL)

Behavioral

A certified recovery coach will meet with participants to educate them on recovery support services, including recovery community centers, and link them to a recovery community center, with the aid of a facilitated connection to a volunteer recovery community center member (e.g., calling a standby peer, scheduling a meet-up at the center). The coach will also provide the participant with a brochure of recovery support resources.

Control Condition (CC)

Behavioral

A certified recovery coach will meet with participants to educate them on recovery support services more broadly, including recovery community centers, and will provide them with a brochure of recovery support resources.

Primary outcomes

  1. Overall recruitment feasibility

    Time frame: Through study completion, ~3 years from recruitment initiation

    Number of participants successfully recruited within allotted recruitment time frame (~3 years)

  2. Overall intervention feasibility

    Time frame: From the date of intervention manual finalization until the date of study completion, assessed up to 48 months

    Assessed via the Feasibility: Intervention Implementation & Training scale average total score. This is a 2-item instrument to assess perceived intervention feasibility. Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree). Score is the calculated mean. Higher scores indicate greater feasibility.

  3. Fidelity: Linkage manager adherence

    Time frame: From date of first linkage manager meeting until the date of last linkage manager meeting, assessed up to 36 months

    Percent adherence of linkage managers to intervention protocols, as evaluated by the percentage of sessions that are scored with adequate adherence and assessed by recordings of intervention delivery and adherence evaluation materials developed as part of Aim 1 (e.g., adherence rating scales of critical topics). This is a 14-item instrument evaluating the extensiveness of linkage managers' delivery of critical intervention topics. Items are measured on a 5-point Likert scale (Not at all - Extensively). Score is the calculated mean. Total scores range from 1 to 5, with scores > 3 indicating adequate adherence.

  4. Overall intervention acceptability

    Time frame: Month 1

    Assessed via 1 single-item statement addressing the the acceptability of the intervention. The item is measured on a 6-point Likert scale (Strongly Disagree - Strongly Agree). Higher scores indicate greater acceptability.

  5. Overall intervention satisfaction

    Time frame: Month 1

    Assessed via the Client Satisfaction Questionnaire-8 (CSQ8) total score. This is an 8 item measure of client satisfaction with services. Total scores range from 8 to 32, with higher scores indicating greater satisfaction.

  6. Recovery community center attendance

    Time frame: From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months

    Percent of participants who attended a recovery community center 1+ time post linkage manager meeting, as assessed via the Timeline Follow Back

  7. Use of recovery support services

    Time frame: From the date of linkage manager meeting until the date of month-3 follow up, assessed up to 3 months

    Percent days use of any recovery support services post linkage manager meeting, as assessed via the Timeline Follow Back

Secondary outcomes

  1. Participant retention

    Time frame: From the date of first participant enrollment in the trial to the date of study completion, up to 42 months

    Percent of enrolled participants who complete Month 3 Follow-Up

  2. Feasibility of peer facilitator meet-ups

    Time frame: Month 1; Month 3

    Percent of peer facilitator meet-ups occurring within 2 weeks of participant's linkage manager meeting

  3. Intervention appropriateness

    Time frame: Month 1

    Assessed via the Intervention Appropriateness Measure (IAM; adapted for study parameters) average total score. This is a 4-item instrument to assess perceived intervention appropriateness. Items are measured on a 5-point Likert scale (Strongly Disagree-Strongly Agree). Score is the calculated mean. Higher scores indicate greater appropriateness.

  4. Intervention helpfulness

    Time frame: Month 1; Month 3

    Assessed via 4 single-item statements addressing the intervention's helpfulness in general and helpfulness to supporting treatment and opioid use disorder recovery. Items are measured on a 6-point Likert scale (Strongly Disagree-Strongly Agree). Score is the response for each item. Higher scores indicate greater helpfulness.

  5. Change in recovery capital from baseline to Month 3

    Time frame: Baseline; Month 1; Month 3

    Assessed via the REC-CAP Inventory total score. Scores range from -100 to +100, with higher scores indicating greater recovery capital.

Study contacts

Contact information is provided by the study sponsor or research team.

John F Kelly, PhD

CONTACT

[email protected]

(617) 643-1980

Lauren A Hoffman, PhD

CONTACT

[email protected]

(617) 643-4690

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Official study title

Developing and Testing an Intervention to Enhance Recovery Capital Amid Opioid Use Disorder Pharmacotherapy: A Pilot Randomized Trial of Linkage to Recovery Support Services

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Feb 18, 2022
Registry last updated
Sep 26, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.